Does Mounjaro Make You Horny — or Does It Reduce Your Sex Drive?

What the SURMOUNT trials recorded — and what they didn't

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and followed them for 72 weeks. Participants at the highest dose lost an average of around 20–21% of their body weight. The trial measured dozens of endpoints (blood pressure, waist circumference, glycaemic markers, quality of life) but libido was not among them, and increased sexual desire did not appear in the side-effect data. Neither did reduced libido as an adverse event. That absence is itself informative: if tirzepatide were triggering a meaningful hormonal shift in either direction via a direct mechanism, signal would almost certainly have surfaced across a trial that size.

The NHS tirzepatide patient information lists the known side effects of Mounjaro in detail. Changes in sexual desire are not on the list. That does not mean no individual will notice a shift, it means the shift, where it occurs, is likely downstream of the weight and metabolic changes rather than a direct drug action.

So where does the question come from? Partly from social media, where anecdotal reports spread fast. And partly because, for many people, something genuinely does change in this area during treatment. The mechanism is worth understanding.

Why some people do notice a change in sexual interest during treatment

Weight loss at the scale tirzepatide produces can measurably alter sex hormone concentrations. In men, excess adipose tissue converts testosterone to oestrogen through an enzyme called aromatase; as fat mass falls, that conversion rate drops, and free testosterone can rise. In women, the picture is more complex, oestrogen is partly produced in fat tissue, so significant loss may shift that balance too, with effects that vary by menopausal status, cycle regularity, and baseline hormone levels. None of this is unique to Mounjaro; it is a consequence of substantial, sustained weight reduction by any means.

There is also the metabolic picture. Improved insulin sensitivity, lower blood pressure, and better sleep (all documented in the SURMOUNT programme) contribute to energy, mood, and physical comfort in ways that can ripple into sexual wellbeing. A person who previously felt exhausted by daily activity and is now moving more easily may simply feel more present in their body. That matters. At the same time, how Mounjaro makes you feel in the early weeks (particularly nausea, fatigue, and GI discomfort) can temporarily suppress interest in sex, and that is entirely normal. Most of those effects ease as the body adjusts to the dose.

If you want to understand the broader picture of physical sensations during treatment, our Mounjaro overview covers what to expect across the full titration schedule.

Other physical changes that prompt this question

Some people searching this query have noticed other body-temperature or physical sensations and are working out what to attribute to the medicine. It is worth knowing that flushing and warmth can occur on GLP-1 and dual-agonist medicines, there is a separate question about whether Mounjaro makes you feel hot that covers that specifically. Similarly, aching or unusual physical sensations during dose increases have their own pattern; the Mounjaro and muscle ache page goes into that in detail.

A practical check worth doing: scroll through the Patient Information Leaflet that came with your pen (or download it from the electronic Medicines Compendium). It lists every side effect reported in trials, ranked by frequency. Running your finger down that list takes under a minute and will tell you quickly whether what you are experiencing has a documented link to the medicine. If your symptom is not there, it may still be real (bodies are individual) but the link to tirzepatide is less established.

For anything that feels persistent, distressing, or out of character, the right step is to raise it with your prescriber rather than draw conclusions from online threads. If you are thinking about what treatment involves more broadly, our tirzepatide information page is a good starting point, and a look at how Mounjaro is priced across providers can help you understand the private route. Changes to mood or emotional wellbeing during treatment also deserve attention, our page on whether Mounjaro affects how you look and feel over time touches on some of those broader questions.

When to speak to a prescriber

A change in sexual desire, whether an increase or a reduction, is not a reason to stop treatment without clinical advice. If it is mild and seems tied to the early weeks of a new dose, give it time. If it persists, feels significant, or coincides with mood changes, low energy, or other symptoms you weren't expecting, tell your prescriber. Hormonal changes that follow weight loss sometimes need monitoring, particularly if you have a history of hormone-sensitive conditions.

People on oral contraceptives should be aware of a separate, specific consideration: during the first four weeks of tirzepatide treatment and for four weeks after each dose increase, absorption of oral hormonal contraception may be reduced. NHS guidance recommends adding a barrier method during those windows. This is a clinical detail that matters regardless of whether libido is your concern, NHS England's weight management injections guidance covers it clearly. If you use hormonal contraception and are starting or adjusting Mounjaro, raise it at your next clinical review. Fatigue that persists beyond the first few weeks of a dose is also worth flagging; the Mounjaro and feeling cold page covers energy-related sensations that sometimes get conflated. Speak to our prescribers if you have questions about how treatment is affecting you.